Clinical trial · Interventional
Comparison of a Web-based Advance Directive to a Standard Advance Directive
Comparison of a Web-based Advance Directive to a Standard Advance Directive: Randomized Evaluation
NCT03676426CI-TRIAL-00044995completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will compare a web-based advance directive to a standard advance directive.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| GI Cancer | Digestive System Neoplasm | PROBABILISTIC | 0.70 |
| Thoracic Cancer | Malignant Thoracic Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Standard advance directive | Other | — | UNRESOLVED |
| Web platform for advance care planning/advance directive | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Web-based AD
- description
- Patients will be encouraged to use the web platform for advance care planning/advance directive to document their care preferences..
- interventionNames
- Other: Web platform for advance care planning/advance directive
- type
- ACTIVE_COMPARATOR
- label
- Paper AD
- description
- Patients will be given the standard advance directive and encouraged to complete on their own.
- interventionNames
- Other: Standard advance directive
Primary outcomes (1)
- measure
- New documentation of advance care planning in the EHR
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria (any of the following) * Pancreatic cancer, any stage except stage 0 (C25), * NSCLC, stage IIIA or higher (C34), * SCLC, any stage (C34), * Colon cancer, stage IIIB or greater (C18), * Rectal cancer, stage IIB or greater (C21), * Esophageal cancer (adeno or squamous), any stage (C15), * Stomach cancer, stage IIB or greater (C16), * Gallbladder cancer, stage I or greater (C23), * Cholangiocarcinoma, any stage (C22.1), * HCC, any stage (no plan for transplant) (C22.0), * Malignant carcinoid of GI tract, stage IV (C7A.019). Exclusion criteria: * Does not have an active patient portal (MyPennMedicine) account, * Does not use email at least once per month, * Has already completed a living will, * Does not speak fluent English, * Unwilling to be contacted by email, * Determined to be too ill or inappropriate for participation by patient's oncologist.
References
Publications (2)
- BACKGROUNDHalpern SD, Loewenstein G, Volpp KG, Cooney E, Vranas K, Quill CM, McKenzie MS, Harhay MO, Gabler NB, Silva T, Arnold R, Angus DC, Bryce C. Default options in advance directives influence how patients set goals for end-of-life care. Health Aff (Millwood). 2013 Feb;32(2):408-17. doi: 10.1377/hlthaff.2012.0895. PMID 23381535
- BACKGROUNDSudore RL, Landefeld CS, Barnes DE, Lindquist K, Williams BA, Brody R, Schillinger D. An advance directive redesigned to meet the literacy level of most adults: a randomized trial. Patient Educ Couns. 2007 Dec;69(1-3):165-95. doi: 10.1016/j.pec.2007.08.015. Epub 2007 Oct 17. PMID 17942272